![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
ESMO 2024: Adding Metformin to ADT for Patients with mHSPC: …
(UroToday.com) The 2024 ESMO annual meeting included a session on prostate cancer, featuring a presentation by Dr. Silke Gillessen discussing results from STAMPEDE assessing the addition of metformin to ADT for patients with mHSPC.
Erectile dysfunction prevalence in the United States: report
Mar 4, 2024 · There has been a great deal of public speculation regarding a surge in erectile dysfunction (ED) in younger men despite data consistently indicating that the ED prevalence rates increase with age.In this study we sought to assess the prevalence and risk of experiencing ED in a nationally representative sample of men in the United States across various social groups, describe comorbidities, and ...
UroToday - The Global Online Community of Urologists
The 2024 ESMO annual meeting included a session on prostate cancer, featuring a discussion presentation by Dr. Niven Mehra discussing three abstracts including “Efficacy and safety of darolutamide plus ADT in patients with mHSPC from the phase 3 ARANOTE trial” by Dr. Fred Saad, “Prostate cancer efficacy results from a randomized phase 3 evaluation of transdermal estradiol versus LHRH ...
Upcoming Events for Urologists and Oncologists - UroToday
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.
Gentamicin Bladder Irrigation to Reduce UTIs - Anne Cameron
May 8, 2019 · Anne Cameron, MD, discusses the use of gentamicin bladder irrigation for the prevention of symptomatic urinary tract infections (UTIs) in neurogenic bladder patients with intermittent catheterization. Gentamicin is not absorbed through the bladder, therefore, there are no concerns with the development of antibiotic resistance or potential toxicity. Dr. Cameron reviews the protocol for ...
The Latest Research in Erectile Dysfunction
Jan 8, 2025 · The association between comprehensive dietary antioxidant index and erectile dysfunction in adult men: a cross-sectional study from the 2001-2004 U.S. National Health and Nutrition Examination Survey.
Treatment Outcomes and Estimated Costs Associated with BCG
May 25, 2021 Non-muscle invasive bladder cancers (NMIBC) constitute the majority of bladder cancer diagnoses. NMIBCs are stratified based on the risk of progression to muscle-invasive disease into low, intermediate, and high-risk groups.
A Review on Penile Doppler and Ultrasonography for Erectile
Feb 2, 2023 · Penile duplex Doppler Ultrasound (PDDU), erectile dysfunction (ED), Peyronie’s disease, nocturnal penile tumescence, injection cavernosometry, PDE-5 inhibitors, vascular erectile dysfunction.
COURAGE Trial: Vibegron for BPH Patients with Persistent OAB …
David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite alpha-blocker treatment. The study demonstrates significant improvements in various urinary symptoms, including micturitions, urgency episodes, and nocturia. Dr. Staskin highlights the drug's favorable ...
AUA 2020: Complicated UTI Management - UroToday
(UroToday.com) In her presentation at AUA 2020 on the management of urinary tract infections (UTI), physician assistant Brooke Zilinskas began by providing definitions: UTI is bacteriuria with symptoms Asymptomatic bacteriuria may be colonization or contamination of the bladder with bacteria Pyuria ...